#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma stage I Dermatitis Synovitis Systemic lupus erythematosus Trigeminal neuralgia Angiosarcoma non-metastatic Philadelphia positive chronic myeloid leukaemia Rectal cancer Follicle centre lymphoma follicular grade I II – III refractory Prolymphocytic leukaemia Non-Hodgkin's lymphoma Anaplastic thyroid cancer Non-small cell lung cancer recurrent Anal fistula Oropharyngeal cancer recurrent More trials…

    Learn about Rare Diseases

    Tuberous sclerosis complex – Trials in Disease Waldenstrom’s macroglobulinaemia VEXAS syndrome – Trials in Disease Lymphangioma – Trials in Disease Castleman’s disease Chordoma Basal cell naevus syndrome – Treatment Alexander disease – Treatment Crigler-Najjar syndrome Hereditary hypophosphataemic rickets – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dc-806 Metolazone IMMUNOSTEM Tryptophan Albumin Lutetium (177Lu) Oxodotreotide Hypromellose Tiotropium Bromide Famotidine Collagenase Atorvastatin Gliquidone Dmd06-Mab ZIRCONIUM (89ZR) GIRENTUXIMAB Prasugrel Hydrobromide Indacaterol Doxorubicin Hydrochloride Sapablursen Naproxen Sodium Dexmedetomidine More therapies…

    Learn about Your Condition

    Pterygium Breast cancer in situ Thrombectomy Fallopian tube cancer stage IV Antisynthetase syndrome Haemofiltration Endometrial adenocarcinoma Advanced systemic mastocytosis Ewing's sarcoma Aplasia pure red cell Cirrhosis alcoholic Lymphoma Atrial fibrillation Gout EGFR gene mutation More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study of Pneumococcal Vaccine Response in Patients Without a Spleen: Comparing Vaccination Before and After Spleen Removal Using PCV20 and PCV21

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Asplenia
    Investigated Drugs:
    • Pneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 11A Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    • Pneumococcal Polysaccharide Serotype 12F Conjugated To Crm197 Adsorbed On Aluminium Phosphate
    The Netherlands

  • Study of High-Flow Nasal Oxygen During Intubation in Intensive Care Patients with Low Blood Oxygen Levels

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Acute respiratory failure
    Investigated Drugs:
    • Oxygen
    France

  • Study of Human Albumin Treatment to Prevent Kidney Dysfunction in Adult Patients After Liver Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Liver transplant
    Investigated Drugs:
    • Human Albumin Solution
    France

  • Study of levodopa and carbidopa treatment for patients with neurodevelopmental disorder caused by CTNNB1 gene mutation

    Recruiting

    2 1 1
    Investigated Diseases:
    • Neurodevelopmental disorder
    Investigated Drugs:
    • Carbidopa
    • Levodopa
    France

  • Study of intraperitoneal paclitaxel combined with systemic therapy versus systemic therapy alone for patients with gastric cancer and peritoneal metastases

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Metastatic gastric cancer
    Investigated Drugs:
    • Irinotecan Hydrochloride
    • Zolbetuximab
    • Capecitabine
    Italy The Netherlands Norway Sweden

  • Study of durvalumab and tremelimumab with or without hepatic arterial infusion of gemcitabine and oxaliplatin in patients with high tumor burden hepatocellular carcinoma

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Hepatocellular carcinoma
    Investigated Drugs:
    • Gemcitabine
    • Oxaliplatin
    • Durvalumab
    France
Previous Page
1 … 129 130 131 132 133 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!